Clinical Trials in Guanzhou, China
5 recruiting
Showing 1–20 of 29 trials
Recruiting
Not Applicable
Proton Therapy for Recurrent Nasopharyngeal Carcinoma
Recurrent Nasopharyngeal Carcinoma
Guangzhou Concord Cancer Center52 enrolled2 locationsNCT07412314
Recruiting
Phase 3
AK112 and Chemotherapy in First-line Metastatic Colorectal Cancer
Colorectal Adenocarcinoma
Akeso560 enrolled2 locationsNCT06951503
Recruiting
Phase 1Phase 2
ZG006 and ZG005 in Participants With Small Cell Lung Cancer or Neuroendocrine Carcinoma
Small Cell Lung CancerNeuroendocrine Carcinoma
Suzhou Zelgen Biopharmaceuticals Co.,Ltd350 enrolled1 locationNCT07038096
Recruiting
Phase 4
ASPIrin in Reducing Events in Dialysis ( ASPIRED )
CKD (Chronic Kidney Disease) Stage 5D
Guangdong Provincial People's Hospital9,000 enrolled139 locationsNCT04381143
Recruiting
Phase 1Phase 2
Single Arm Study of Post-transplant Azacitidine and Chidamide for Prevention of Acute Myelogenous Leukemia Relapse
Leukemia, Myeloid, Acute
Zhujiang Hospital20 enrolled1 locationNCT05270200
Recruiting
Phase 3
JSKN003 Versus Treatment Of Physician'S Choice For HER2-low, Unresectable and/or Metastatic Breast Cancer Subjects
Breast Cancer
Jiangsu Alphamab Biopharmaceuticals Co., Ltd400 enrolled87 locationsNCT06079983
Recruiting
Phase 3
A Study to Evaluate HMPL-306 in Patients With IDH1or IDH2-mutated Acute Myeloid Leukemia
Acute Myeloid Leukemia
Hutchmed316 enrolled53 locationsNCT06387069
Recruiting
Phase 2
RC48 in Combination With AK104 and Bevacizumab in OCCC
Ovary Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University39 enrolled1 locationNCT06540729
Recruiting
Characteristics and Clinical Significance of Gut Microbiota in Patients With Monoclonal Gammopathy
Multiple MyelomaMonoclonal Gammopathy of Undetermined Significance (MGUS)M-Protein+1 more
Zhujiang Hospital2,990 enrolled1 locationNCT06690593
Recruiting
Phase 1Phase 2
A Study of GFH009 Monotherapy in Patients with Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)
Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)
Genfleet Therapeutics (Shanghai) Inc.95 enrolled1 locationNCT05934513
Recruiting
Not Applicable
bTAE-HAIC Combined With System Therapy for Intermediate-advanced Huge HCC
Hepatocellular CarcinomaImmunotherapyCamrelizumab+2 more
Sun Yat-sen University40 enrolled1 locationNCT06061276
Recruiting
Intestinal Flora and Immunity in Monoclonal Gammopathy Patients
Multiple MyelomaInfectionsMGUS+2 more
Zhujiang Hospital300 enrolled1 locationNCT06539832
Recruiting
Effects of Neoadjuvant Therapy With Carboplatin, Paclitaxel Combined With Anti-PD-1 Drugs on Pain, Anxiety and Depression in Patients With Resectable Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University302 enrolled1 locationNCT06575322
Recruiting
Effects of Neoadjuvant Therapy With Carboplatin, Paclitaxel Combined With Anti-PD-1 Drugs on Cognitive Function in Patients With Resectable Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University306 enrolled1 locationNCT06576180
Recruiting
Adding Of Naxitamb In Induction Therapy For High Risk Neuroblastoma
NeuroblastomaGD2 Antibody (Naxitamab)
Guangzhou Women and Children's Medical Center64 enrolled1 locationNCT06574698
Recruiting
Phase 1
CT011 Autologous CAR-T Cells in Patients With Hepatocellular Carcinoma at Risk of Recurrence After Surgical Resection
HCC
CARsgen Therapeutics Co., Ltd.30 enrolled15 locationsNCT06560827
Recruiting
Phase 2
Neoadjuvant Intra-tumor Double Immunotherapy for Hepatocellular Carcinoma.
SurgeryHepatic Cancer
Second Affiliated Hospital of Guangzhou Medical University90 enrolled1 locationNCT06492408
Recruiting
Phase 2
Neoadjuvant Intra-tumor Double Immunotherapy for Lung Cancer.
SurgeryLung CancerNon-small Cell Lung Cancer
Second Affiliated Hospital of Guangzhou Medical University90 enrolled1 locationNCT06492421
Recruiting
Phase 2Phase 3
Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors
Breast CancerOvarian CancerCervical Cancer+7 more
Second Affiliated Hospital of Guangzhou Medical University200 enrolled1 locationNCT03755739
Recruiting
Phase 3
Infusion of PD1/PDL1/CTLA4 Inhibitors Via Hepatic Arterial for Immunotherapy of Hepatocellular Carcinoma
Liver Cancer
Second Affiliated Hospital of Guangzhou Medical University200 enrolled1 locationNCT03949231